HQL vs. THQ

Last updated Jun 24, 2026

HQL (Tekla Life Sciences Investors) is a stock, while THQ (Abrdn Healthcare Opportunities Fund) is Health & Biotech Equities fund managed by Aberdeen. Over the past 10 years, HQL returned 10.98%/yr vs 10.24%/yr for THQ. A 0.66 correlation means they provide meaningful diversification when combined.

Performance

HQL vs. THQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tekla Life Sciences Investors (HQL) and Abrdn Healthcare Opportunities Fund (THQ). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, HQL achieves a 18.47% return, which is significantly higher than THQ's 4.47% return. Over the past 10 years, HQL has outperformed THQ with an annualized return of 10.98%, while THQ has yielded a comparatively lower 10.24% annualized return.

HQL

• 1D: 1.58%
• 1M: 8.38%
• YTD: 18.47%
• 6M: 15.24%
• 1Y: 69.35%
• 3Y*: 25.15%
• 5Y*: 9.02%
• 10Y*: 10.98%

THQ

• 1D: 0.80%
• 1M: 2.93%
• YTD: 4.47%
• 6M: 5.51%
• 1Y: 19.51%
• 3Y*: 10.70%
• 5Y*: 5.26%
• 10Y*: 10.24%

*Multi-year figures are annualized to reflect compound growth (CAGR)

HQL vs. THQ - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
HQL Tekla Life Sciences Investors	18.47%	45.48%	11.03%	4.23%	-19.21%	5.52%	23.72%	25.53%	-16.18%	25.41%
THQ Abrdn Healthcare Opportunities Fund	4.47%	13.88%	15.51%	-1.62%	-17.53%	33.39%	15.20%	22.70%	3.41%	21.84%

Correlation

The correlation between HQL and THQ is 0.51, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.51
Correlation (3Y) Calculated over the trailing 3-year period	0.60
Correlation (5Y) Calculated over the trailing 5-year period	0.64
Correlation (10Y) Calculated over the trailing 10-year period	0.67
Correlation (All Time) Calculated using the full available price history since Jul 29, 2014	0.66

The correlation between HQL and THQ shifts across timeframes, from 0.51 (1 year) to 0.67 (10 years), reflecting how their relationship changes across market environments.

Return for Risk

HQL vs. THQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HQL

HQL Risk / Return Rank: 95
HQL Sharpe Ratio Rank: 96
HQL Sortino Ratio Rank: 96
HQL Omega Ratio Rank: 94
HQL Calmar Ratio Rank: 95
HQL Martin Ratio Rank: 96

THQ

THQ Risk / Return Rank: 15
THQ Sharpe Ratio Rank: 16
THQ Sortino Ratio Rank: 17
THQ Omega Ratio Rank: 16
THQ Calmar Ratio Rank: 13
THQ Martin Ratio Rank: 11

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HQL vs. THQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tekla Life Sciences Investors (HQL) and Abrdn Healthcare Opportunities Fund (THQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	HQL	THQ	Difference
Sharpe ratio: Return per unit of total volatility	3.22	1.07	+2.15
Sortino ratio: Return per unit of downside risk	4.13	1.61	+2.53
Omega ratio: Gain probability vs. loss probability	1.51	1.19	+0.32
Calmar ratio: Return relative to maximum drawdown	6.80	1.14	+5.66
Martin ratio: Return relative to average drawdown	21.70	3.09	+18.61

HQL vs. THQ - Sharpe Ratio Comparison

The current HQL Sharpe Ratio is 3.22, which is higher than the THQ Sharpe Ratio of 1.07. The chart below compares the historical Sharpe Ratios of HQL and THQ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

HQL vs. THQ - Drawdown Comparison

The maximum HQL drawdown since its inception was -62.65%, which is greater than THQ's maximum drawdown of -39.35%. Use the drawdown chart below to compare losses from any high point for HQL and THQ.

Drawdown Indicators

	HQL	THQ	Difference
Max Drawdown Largest peak-to-trough decline	-62.65%	-39.35%	-23.30%
Max Drawdown (1Y) Largest decline over 1 year	-10.25%	-17.25%	+7.00%
Max Drawdown (3Y) Largest decline over 3 years	-25.10%	-25.86%	+0.76%
Max Drawdown (5Y) Largest decline over 5 years	-38.86%	-32.20%	-6.66%
Max Drawdown (10Y) Largest decline over 10 years	-38.86%	-39.35%	+0.49%
Current Drawdown Current decline from peak	0.00%	-1.11%	+1.11%
Average Drawdown Average peak-to-trough decline	-22.24%	-8.61%	-13.63%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.21%	6.33%	-3.12%

Volatility

HQL vs. THQ - Volatility Comparison

Tekla Life Sciences Investors (HQL) has a higher volatility of 7.57% compared to Abrdn Healthcare Opportunities Fund (THQ) at 5.51%. This indicates that HQL's price experiences larger fluctuations and is considered to be riskier than THQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	HQL	THQ	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.57%	5.51%	+2.06%
Volatility (6M) Calculated over the trailing 6-month period	15.13%	13.00%	+2.13%
Volatility (1Y) Calculated over the trailing 1-year period	21.66%	18.33%	+3.33%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	20.76%	19.07%	+1.69%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	22.29%	20.49%	+1.80%

Dividends

HQL vs. THQ - Dividend Comparison

HQL's dividend yield for the trailing twelve months is around 10.95%, less than THQ's 11.45% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
HQL Tekla Life Sciences Investors	10.95%	10.85%	14.18%	9.44%	9.57%	8.79%	7.90%	8.03%	10.72%	8.25%	12.18%	11.84%
THQ Abrdn Healthcare Opportunities Fund	11.45%	11.29%	11.09%	7.45%	6.81%	5.27%	6.62%	7.08%	8.05%	7.71%	8.70%	9.50%

Frequently Asked Questions

Can I hold both HQL and THQ in my portfolio?

HQL and THQ have a correlation of 0.51, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, HQL or THQ?

HQL has higher volatility (7.57%) compared to THQ (5.51%). In terms of maximum drawdown, HQL dropped -62.65% vs THQ's -39.35%.

Which has better risk-adjusted returns?

HQL currently has the higher Sharpe Ratio (3.22 vs 1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.